Rotella Capital Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Rotella Capital Management’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,304	Closed	-$64K	–	645
2015 Q3	$64K	Buy	+1,304	New	+$91.1K	0.02%	481
2015 Q1	–	Sell	-1,941	Closed	-$25K	–	648
2014 Q4	$25K	Buy	+1,941	New	+$28.2K	0.02%	335
2014 Q3	–	Sell	-3,314	Closed	-$90K	–	443
2014 Q2	$90K	Buy	3,314 +576	+21%	+$14.2K	0.08%	239
2014 Q1	$73K	Buy	+2,738	New	+$69.5K	0.09%	135

Other funds holding ANTH

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Rotella Capital Management's ANTH Position: Q4 2015 in Review

Rotella Capital Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q4 2015, closing a stake of 1,304 shares — an estimated $64K sold.

Rotella Capital Management first reported a position in ANTH in Q1 2014 and held it in 4 quarters. The position peaked at $90K in Q2 2014. 86 funds tracked by Wall St. Rank hold ANTH as of Q4 2015.

Rotella Capital Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
Rotella Capital Management sold 1,304 Anthera Pharmaceuticals, Inc. shares in Q4 2015, an estimated $64K.
Rotella Capital Management first reported a position in Anthera Pharmaceuticals, Inc. in Q1 2014 and held it in 4 quarters.
Rotella Capital Management's Anthera Pharmaceuticals, Inc. position peaked at $90K in Q2 2014.
86 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q4 2015.

Based on Rotella Capital Management's 13F filing for Q4 2015, filed 9 Feb 2016.